Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These findings support the appropriateness of considering biologic therapies for patients with low BSA and indicators of high disease burden
He has received clinical study grants from Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Clovis, Eisai, Eli Lilly, GSK, Ipsen, Johnson & Johnson, MSD, Novartis, Pfizer, Roche, Servier, Incyte, MRM Health and Sanofi, all paid to the Netherlands Cancer Institute
Steroid Tested
Pricing can change
Remember, you are not your diagnosis
US$ 26.77
US$ 24.64
US$ 26.30
US$ 23.80
US$ 28.77
